|
ATE123066T1
(de)
|
1988-03-11 |
1995-06-15 |
Biomembrane Inst |
Monoklonale antikörper und herstellung eines impfstoffes gegen menschliche krebsantigene durch immunisierung mit menschlichem und tierischem mucin und mit synthetischen gluciden- trägerkonjugaten.
|
|
US7147850B2
(en)
|
1999-08-18 |
2006-12-12 |
Altarex Medical Corp. |
Therapeutic binding agents against MUC-1 antigen and methods for their use
|
|
WO2001075110A2
(en)
|
2000-03-30 |
2001-10-11 |
Dyax Corp. |
Mucin-1 specific binding members and methods of use thereof
|
|
US7338932B2
(en)
|
2000-05-11 |
2008-03-04 |
Glycozym Aps |
Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
|
|
US7214786B2
(en)
|
2000-12-14 |
2007-05-08 |
Kovalic David K |
Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
|
|
CN1141142C
(zh)
*
|
2001-02-08 |
2004-03-10 |
北京迪威华宇生物技术有限公司 |
人乳腺癌muc-1抗原基因工程疫苗
|
|
DE10303664A1
(de)
|
2003-01-23 |
2004-08-12 |
Nemod Immuntherapie Ag |
Erkennungsmoleküle zur Behandlung und Detektion von Tumoren
|
|
EP2083868A2
(en)
|
2006-10-04 |
2009-08-05 |
Københavns Universitet |
Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies
|
|
WO2008119353A1
(en)
|
2007-03-29 |
2008-10-09 |
Genmab A/S |
Bispecific antibodies and methods for production thereof
|
|
EP2014302A1
(en)
|
2007-07-12 |
2009-01-14 |
Institut Curie |
An antibody specific for the Tn antigen for the treatment of cancer
|
|
TWI405770B
(zh)
*
|
2007-07-31 |
2013-08-21 |
Glytech Inc |
Production of peptides
|
|
JP5532401B2
(ja)
|
2007-12-05 |
2014-06-25 |
協和発酵キリン株式会社 |
ヘパリン結合上皮細胞増殖因子様増殖因子に結合するモノクローナル抗体
|
|
US20090162359A1
(en)
|
2007-12-21 |
2009-06-25 |
Christian Klein |
Bivalent, bispecific antibodies
|
|
JP5773352B2
(ja)
|
2008-10-28 |
2015-09-02 |
塩野義製薬株式会社 |
抗ｍｕｃ１抗体
|
|
TW201100543A
(en)
|
2009-05-27 |
2011-01-01 |
Hoffmann La Roche |
Tri-or tetraspecific antibodies
|
|
EP2281844A1
(en)
*
|
2009-07-31 |
2011-02-09 |
Glycotope GmbH |
MUC 1 antibodies
|
|
WO2011054359A2
(en)
*
|
2009-11-06 |
2011-05-12 |
University Of Copenhagen |
Method for early detection of cancer
|
|
JP5660486B2
(ja)
|
2010-02-12 |
2015-01-28 |
国立大学法人 鹿児島大学 |
ムチン１（ｍｕｃ１）タンパク質に対する抗体及びその用途
|
|
EP2565268A4
(en)
|
2010-04-28 |
2013-10-09 |
Shionogi & Co |
NEW MUC1 ANTIBODY
|
|
EP2407487A1
(en)
*
|
2010-07-14 |
2012-01-18 |
F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. |
Multispecific modular antibody
|
|
EP2855531A1
(en)
|
2012-05-24 |
2015-04-08 |
F. Hoffmann-La Roche AG |
Multispecific antibodies
|
|
AU2013302696B9
(en)
|
2012-08-14 |
2018-08-09 |
Ibc Pharmaceuticals, Inc. |
T-cell redirecting bispecific antibodies for treatment of disease
|
|
EP3470431A1
(en)
|
2012-09-27 |
2019-04-17 |
Merus N.V. |
Bispecific igg antibodies as t cell engagers
|
|
EP2981281B1
(en)
*
|
2013-04-03 |
2020-07-15 |
IBC Pharmaceuticals, Inc. |
Combination therapy for inducing immune response to disease
|
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
|
US20170145108A1
(en)
|
2014-02-05 |
2017-05-25 |
The University Of Chicago |
Chimeric antigen receptors recognizing cancer-specific tn glycopeptide variants
|
|
AU2015254257B2
(en)
|
2014-04-28 |
2021-02-25 |
Medicinal Chemistry Pharmaceuticals, Co., Ltd. |
Anti-MUC1 antibody or antigen-binding fragment of same, and use thereof
|
|
US20170129962A1
(en)
|
2015-10-02 |
2017-05-11 |
Hoffmann-La Roche Inc. |
Multispecific antibodies
|
|
EP3150636A1
(en)
|
2015-10-02 |
2017-04-05 |
F. Hoffmann-La Roche AG |
Tetravalent multispecific antibodies
|
|
AU2018241781A1
(en)
|
2017-03-29 |
2019-07-18 |
Glycotope Gmbh |
Multispecific antibody constructs binding to MUC1 and CD3
|